Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AZN vs GSK✓SelectedUSD · GSKAZN vs GSK performance historyLatest closeAs of-1.93%11/18
Stock and ETF performance explorer

AZN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+73.7%
GSK return
+42.7%
Excess return
+31.1%
Maximum drawdown
-27.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%-1.3%-0.6%-1.2%
7D-3.6%-3.1%-0.5%-1.9%
30D+9.0%-0.9%+9.9%+9.5%
3M+11.7%-4.2%+15.8%+14.2%
6M-2.8%-1.6%-1.2%-2.0%
YTD-1.8%+2.6%-4.4%-3.5%
1Y+0.9%+6.2%-5.4%-2.7%
3Y+46.9%+55.0%-8.0%+12.7%
5Y+73.7%+42.8%+30.9%+39.4%
All+73.7%+42.7%+31.1%+39.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling